Please Wait
Applying Filters...
Menu
Xls

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/allegro-ophthalmics-receives-fda-agreement-under-special-protocol-assessment-spa-for-phase-2b3-clinical-trial-of-risuteganib-for-the-treatment-of-intermediate-dry-amd-301795701.html

PR NEWSWIRE
12 Apr 2023

http://www.koreabiomed.com/news/articleView.html?idxno=12885

Lee Han-soo KOREABIOMED
03 Jan 2022